Atezolizumab is a potentially effective treatment option for patients with alveolar soft part sarcoma
Bookmark1. 37% of study patients had an objective response to treatment with atezolizumab. 2....
Read MoreSep 19, 2023
Bookmark1. 37% of study patients had an objective response to treatment with atezolizumab. 2....
Read MoreSep 19, 2023
Bookmark1. The objective response rate was 29.8% (1% complete response, 66% partial response) with...
Read MoreSep 19, 2023
Bookmark1. In this cohort study, using generic versus brand-name fluticasone-salmeterol was...
Read MoreSep 19, 2023
Bookmark1. Despite the decrease in colonoscopies performed at the start of the COVID-19 pandemic,...
Read MoreSep 16, 2023
Bookmark1. In this randomized controlled trial, adjunctive treatment with escitalopram or...
Read MoreSep 16, 2023
Bookmark1. The semaglutide 50 mg group saw a 15.1% reduction in body weight at 68 weeks compared...
Read MoreSep 15, 2023
Bookmark1. In this randomized controlled trial, the triple-hormone-receptor agonist retatrutide...
Read MoreSep 15, 2023
Bookmark1. In this randomized controlled trial, the elective NaV1.8 inhibitor VX-548 reduced acute...
Read MoreSep 15, 2023
Bookmark1. Time to disease flare was significantly shorter in the placebo group versus...
Read MoreSep 15, 2023
Bookmark1. This retrospective cohort study found that higher low-grade inflammation (LGI) scores...
Read MoreSep 14, 2023
Bookmark1. In this randomized controlled trial, infusion of OTQ923 disrupted inhibitory HBG1 and...
Read MoreSep 13, 2023
Bookmark1. Pooled overall survival and progression-free survival HR were found to be 0.95 and 0.88...
Read MoreSep 13, 2023
Bookmark1. In a long-term follow-up study of an earlier randomized control trial, participants...
Read MoreSep 13, 2023
Bookmark1. In this phase three open-label randomized trial, concizumab prophylaxis reduced the...
Read MoreSep 13, 2023
Bookmark1. In this cross-sectional study, rates of statin use for primary prevention were lower...
Read MoreSep 9, 2023
Bookmark1. In this randomized controlled trial, the antibody NI006 for the treatment of...
Read MoreSep 8, 2023
Bookmark1. Children living in areas of North Carolina composed predominantly of non-Hispanic Black...
Read MoreSep 7, 2023
Bookmark1. In this randomized controlled trial, among patients living with human immunodeficiency...
Read MoreSep 7, 2023
Bookmark1. In this pooled analysis of randomized controlled trials, low-dose glucocorticoids...
Read MoreSep 6, 2023
Bookmark1. In this synthetic control analysis, changes in medical cannabis laws were not found to...
Read More